Vimarsana
Biggest News Aggregation in the World

Page 19 - Iagnostics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Iagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Iagnostics Today - Breaking & Trending Today

FIND Joins the Global Health Campus - Vimarsana News

FIND Joins the Global Health Campus

FIND will join the Global Health Campus in the second quarter of 2024.

Tackling Antimicrobial Resistance Together: A Conversation with Dr. Beverley Isherwood - Vimarsana News

Tackling Antimicrobial Resistance Together: A Conversation with Dr. Beverley Isherwood

An interview with Dr Beverley Isherwood.

Global In Vitro Diagnostics Market to Reach $138.4 Billion, Globally by 2032: Allied Market Research - Vimarsana News

Global In Vitro Diagnostics Market to Reach $138.4 Billion, Globally by 2032: Allied Market Research

The global in vitro diagnostics market is expanding rapidly due to a surge in the number of diagnostic laboratories, rise in awareness regarding personalized medicine and early disease diagnosis, and growing prevalence of infectious and chronic diseases.Wilmington, Delaware, Nov. 15, 2023 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, "In Vitro Diagnostics Market by Product and Services (Reagents and Kits, Instruments, Software, and Services), Technique, (Immunodiagnostic

Source: yahoo.com
OraSure to move more work to its Opus Way facility in Bethlehem Twp., CFO says - Vimarsana News

OraSure to move more work to its Opus Way facility in Bethlehem Twp., CFO says

OraSure makes diagnostic kits, such as the InteliSwab home test for COVID-19, and the OraQuick test for HIV.

Source: wfmz.com
Novel assay may improve detection and treatment of acute myeloid leukemia - Vimarsana News

Novel assay may improve detection and treatment of acute myeloid leukemia

A novel assay that detects a unique molecular marker in patients with acute myeloid leukemia (AML) may revolutionize the way this disease is detected and treated according to a new report in The Journal of Molecular Diagnostics published by Elsevier.